Cancer focused bio-pharmaceutical company, Australian Cancer Technology (“AustCancer” - ASX:ACU), is pleased to announce that prominent United States cancer expert Professor Philip Livingston has accepted the company’s invitation to join its Scientific Advisory Board.
